Abstract
Primary headaches (migraines and tension-types headaches) are very common in school-aged children. Ginkgolide B, a herbal constituent extract from Ginkgo biloba tree leaves, was considered as a promising pharmacological aid for the treatment of migraine in adult patients because of its modulation of the glutamatergic transmission in the CNS and on antiplatelet activating factor (PAF). The aim of study is to verify the effectiveness and safety of association of Ginkgolide B/Coenzyme Q10/Riboflavin/Magnesium complex for brief prophylaxis in a population of school-aged children with migraine. In our sample after 3 months of treatment with association of Ginkgolide B/CoenzymeQ10/Riboflavin/Magnesium complex, the mean frequency per month of migraine was significantly decreased (9.71 ± 4.33 vs. 4.53 ± 3.96 attacks; p < 0.001). Our findings suggest that in childhood headache management, the use of alternative treatments must be considered not to evoke a placebo effect, but as soft therapy without adverse reactions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anttila P, Metshäonkala L, Sillanpää M (2004) Secular long trends in headache occurrence in schoolchildren. J Headache Pain 5:65
Mortimer J, Kay J, Jaron A (1992) Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlaquist and IHS criteria. Dev Med Child Neurol 34:1095–1101
Sillanpää M, Piekkala P, Kero P (1991) Prevalence of headaches at preschool age in unselected child population. Cephalalgia 11:239–242
Sillanpää M (1983) Changes in the prevalence of migraine and other headaches during the first seven school years. Headache 23:15–19
Deubner DC (1977) An epidemiological study of migraine and headache in 10–20 year olds. Headache 17:173–180
Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885–890
Condo M, Posar A, Arbizzani A, Parmeggiani A (2009) Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain 10:361–365. doi:10.1007/s10194-009-0142-2
Castelli S, Meossi C, Domenici R, Fontana F, Stefani G (1993) Magnesium in the prophylaxis of primary headache and other periodic disorders in children. Pediatr Med Chir 15(5):481–488
Mazzotta G, Sarchielli P, Alberti A et al (1999) Intracellular Mg ++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia 19:802–809
Mauskop A, Altura BM (1998) Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 5:24–27
Wang F, Van Den Eeden SK, Ackerson LM et al (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601–610
Sándor S, Di Clemente L, Coppola G et al (2005) Efficacy of coenzymeQ10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713
Menke T (2008) Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status. Georgian Med News (156):24–32
Peres MFP (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25:403–411
Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP (2008) Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 29:285–287
Owen JM, Green BN (2004) Homeopathic treatment of headaches: a systematic review of the literature. J Chiropr Med 3(2):45–52
Xia SH, Fang DC (2007) Pharmacological action and mechanisms of ginkgolide B. Chin Med J 120(10):922–928
van Beek TA (2005) Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg Med Chem 13:5001–5012
Vogensen SB, Stromgaard K, Shindou H, Jaracz S, Suehiro M, Ishii S et al (2003) Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. J Med Chem 46:601–608
Bastianetto S, Zheng W-H, Quirion R (2000) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74:2268–2277
Olesen J (2010) Nitric oxide-related drug targets in headache. Neurotherapeutics 7(2):183–190
Williams B, Watanabe CMH, Schultz PG, Rimbach G, Kruker T (2004) Age-related effects of Ginkgo Biloba extract on synaptic plasticity and excitability. Neurobiol Aging 25:955–962
Akisu M, Kultursay N, Coker I, Huseyinov A (1998) Platelet activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo Biloba extracts reduce PAF concentration in the brain. Biol Neonate 74(6):439–444
D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, Moschiano F, Saracco MG, Terzi MG, Petretta V, Benedetto C (2009) Efficacy of Ginkolide B in the prophylaxis of migraine with aura. Neurol Sci 30(Suppl 1):S121–S124
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, edn 2. Cephalalgia 24(Suppl 1):1–15
Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754–762
Conflict of interest
None of the authors have received any financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Esposito, M., Carotenuto, M. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci 32, 79–81 (2011). https://doi.org/10.1007/s10072-010-0411-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-010-0411-5